Irish medical device firm Neuromod scores Series B

Neuromod, an Irish medical device company specializing in the treatment of tinnitus, has raised 10.5 million euros in Series B financing.

20 October 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles